Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -334.84 | 12.37 |
| PEG Ratio (TTM) | 2.73 | 3.86 |
| P/S Ratio (TTM) | 0.40 | 1.45 |
| P/B Ratio (TTM) | 1.39 | -10.33 |
| P/FCF Ratio (TTM) | 5.59 | 19.32 |
| Price to 5YR AVG Earnings Ratio | 10.10 | 19.61 |
| Price to 5YR AVG FCF Ratio | 9.89 | 23.63 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.30% | 5.16% |
| ROE (TTM) | -0.39% | -76.86% |
| Net Profit Margin (TTM) | -0.12% | 0.27% |
| ROIC 5YR AVG | 26.82% | 16.21% |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -170.05% | 337.34% | 198.82% |
| Revenue | -8.11% | 34.30% | 28.45% |
| Net Income | -169.99% | 345.14% | 203.35% |
| Cash Flow | 259.96% | -32.49% | 48.90% |
Health (79%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.79 | 1.36 |
| Quick Ratio (TTM) | 2.79 | 1.26 |
| D/E Ratio (TTM) | N/A | -5.07 |
| Interest Coverage (TTM) | 5.24 | 5.15 |
| Piotroski F-Score | 8 | 6 |
| Altman Z-Score | 5.40 | 2.97 |
| LTL to 5YR AVG FCF | 0.05 | 7.97 |
| Shares Outstanding Growth 5YR AVG | -0.06% | -0.83% |